A detailed history of Atria Investments LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Atria Investments LLC holds 258,306 shares of MRK stock, worth $25 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
258,306
Previous 267,825 3.55%
Holding current value
$25 Million
Previous $33.2 Million 11.53%
% of portfolio
0.39%
Previous 0.45%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$111.15 - $128.97 $1.06 Million - $1.23 Million
-9,519 Reduced 3.55%
258,306 $29.3 Million
Q2 2024

Aug 13, 2024

SELL
$123.8 - $132.96 $498,666 - $535,562
-4,028 Reduced 1.48%
267,825 $33.2 Million
Q1 2024

May 21, 2024

BUY
$113.24 - $131.95 $1.96 Million - $2.28 Million
17,281 Added 6.79%
271,853 $35.9 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $902,120 - $981,725
9,005 Added 3.67%
254,572 $27.8 Million
Q3 2023

Nov 07, 2023

BUY
$102.95 - $114.33 $906,371 - $1.01 Million
8,804 Added 3.72%
245,567 $25.3 Million
Q2 2023

Aug 04, 2023

BUY
$108.61 - $118.38 $513,508 - $559,700
4,728 Added 2.04%
236,763 $27.3 Million
Q1 2023

May 10, 2023

SELL
$102.94 - $114.86 $1.36 Million - $1.52 Million
-13,190 Reduced 5.38%
232,035 $24.7 Million
Q4 2022

Jan 31, 2023

BUY
$87.44 - $112.11 $914,447 - $1.17 Million
10,458 Added 4.45%
245,225 $27.2 Million
Q3 2022

Nov 01, 2022

SELL
$84.53 - $94.96 $837,100 - $940,388
-9,903 Reduced 4.05%
234,767 $20.2 Million
Q2 2022

Aug 11, 2022

BUY
$83.49 - $94.64 $894,595 - $1.01 Million
10,715 Added 4.58%
244,670 $22.3 Million
Q1 2022

May 02, 2022

BUY
$73.51 - $82.4 $244,714 - $274,309
3,329 Added 1.44%
233,955 $19.2 Million
Q4 2021

Feb 04, 2022

BUY
$72.28 - $90.54 $442,931 - $554,829
6,128 Added 2.73%
230,626 $17.7 Million
Q3 2021

Nov 16, 2021

BUY
$71.68 - $78.83 $1.48 Million - $1.62 Million
20,611 Added 10.11%
224,498 $16.9 Million
Q2 2021

Aug 10, 2021

BUY
$70.31 - $77.77 $548,839 - $607,072
7,806 Added 3.98%
203,887 $15.9 Million
Q1 2021

May 11, 2021

BUY
$68.86 - $81.11 $1.26 Million - $1.48 Million
18,274 Added 10.28%
196,081 $15.1 Million
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $1.19 Million - $1.32 Million
16,633 Added 10.32%
177,807 $14.5 Million
Q3 2020

Nov 05, 2020

SELL
$73.18 - $82.95 $376,364 - $426,611
-5,143 Reduced 3.09%
161,174 $13.4 Million
Q2 2020

Sep 22, 2020

BUY
$70.42 - $80.13 $1.6 Million - $1.82 Million
22,655 Added 15.77%
166,317 $12.9 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $1.24 Million - $1.72 Million
-19,592 Reduced 12.0%
143,662 $11.1 Million
Q4 2019

Feb 11, 2020

BUY
$77.58 - $87.54 $5.38 Million - $6.07 Million
69,305 Added 73.77%
163,254 $14.8 Million
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $193,167 - $210,559
2,539 Added 2.78%
93,949 $7.91 Million
Q2 2019

Aug 26, 2019

BUY
$69.84 - $81.59 $6.38 Million - $7.46 Million
91,410 New
91,410 $7.79 Million
Q2 2019

Aug 09, 2019

SELL
$69.84 - $81.59 $5.39 Million - $6.3 Million
-77,229 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $187,866 - $214,272
-2,700 Reduced 3.38%
77,229 $6.42 Million
Q4 2018

Feb 12, 2019

SELL
$65.24 - $75.71 $1.93 Million - $2.25 Million
-29,659 Reduced 27.06%
79,929 $6.11 Million
Q3 2018

Oct 09, 2018

SELL
$57.69 - $67.84 $246,855 - $290,287
-4,279 Reduced 3.76%
109,588 $7.77 Million
Q2 2018

Jul 13, 2018

SELL
$50.83 - $59.72 $450,811 - $529,656
-8,869 Reduced 7.23%
113,867 $6.91 Million
Q1 2018

Apr 30, 2018

BUY
$50.96 - $59.23 $1.76 Million - $2.05 Million
34,593 Added 39.25%
122,736 $6.69 Million
Q4 2017

Jan 16, 2018

BUY
$51.62 - $61.64 $918,577 - $1.1 Million
17,795 Added 25.3%
88,143 $4.96 Million
Q3 2017

Oct 12, 2017

BUY
$58.67 - $63.13 $4.13 Million - $4.44 Million
70,348
70,348 $4.5 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $245B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.